Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn MoreWe believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn MoreWe are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn More
IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn MoreExplore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.
Learn MoreIQVIA Real World Solutions is the proven partner for real-world evidence that meets stakeholder needs with confidence, delivering real impact for clients, clinicians and patients.
IQVIA Real World Solutions is a proven UK partner for the right real-world evidence to meet stakeholder needs with confidence, delivering real results.
IQVIA has taken a leading role in addressing data access challenges by partnering in the development and validation of the Simulacrum. This is a synthetic oncology dataset structured to model properties of the data collected within England’s national registry, the Cancer Analysis System (CAS), one of the largest and most detailed population-based cancer databases in the world.
Simulacrum is generated using sophisticated algorithms and privacy protecting processes to ensure that it contains no actual patient data. IQVIA has leveraged Simulacrum to accelerate real-world insight generation from the actual underlying CAS data. Through this innovative approach, IQVIA has already performed more than 50 clinically relevant and statistically precise studies that answer critical questions about cancer patients and their treatments without compromising patient confidentiality.
In 2022-3, IQVIA piloted an updated version of Simulacrum based on CAS Molecular Diagnostics data, a new dataset that provides information on somatic biomarker testing in routine clinical practice. The outputs of that pilot were published in PHUSE and in a poster presented at ISPOR:
